البحث | Net Pals

sarthak1234 أضاف وظيفة جديدة Health
2026-07-30 07:46:51 - ترجمة -

Targeted Oncology Drugs: The Growing Market for HDAC Inhibitor Therapies
Targeted oncology drugs have revolutionized cancer treatment, offering more precise and effective therapies with fewer side effects compared to traditional chemotherapy. Histone deacetylase (HDAC) inhibitors are a significant class of these targeted agents, working by modulating the epigenome to combat cancer. The market for targeted oncology drugs is expanding, driven by a rising...

0 التعليقات 0 المشاركات 155 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
sarthak1234 أضاف وظيفة جديدة Health
2026-07-08 13:34:30 - ترجمة -

The Evolving Arsenal: How Oncology Chemotherapy Drugs Are Being Augmented by Targeted and Epigenetic Therapies
The landscape of cancer treatment has undergone a dramatic transformation, moving beyond traditional chemotherapy to include a diverse range of targeted and biologic therapies. Oncology chemotherapy drugs now encompass a broad spectrum of agents, from cytotoxic chemotherapies to targeted small molecules, immunotherapies, and epigenetic therapies like decitabine. The global...

0 التعليقات 0 المشاركات 416 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Vanshika04 أضاف وظيفة جديدة Health
2026-05-28 09:01:31 - ترجمة -

Epidermal Growth Factor Receptor Inhibitor Market Growth Drivers and Investment Opportunities
The global Epidermal Growth Factor Receptor (EGFR) inhibitor industry is witnessing substantial momentum due to the increasing prevalence of cancer, growing adoption of targeted therapies, and advancements in precision medicine. The Epidermal Growth Factor Receptor Inhibitor Market size is expected to reach US$ 32.14 Billion by 2034 from US$ 15.92 Billion in 2025. The market is estimated to...

0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
shreymehta0077 أضاف وظيفة جديدة الرئيسية
2026-09-03 08:49:16 - ترجمة -

Global Post-CDK4/6 Treatment Line Oncology Drugs Market Report: Precision Oncology, Treatment Innovation and Growth Prospects
According to the latest report published by Data Bridge Market Research, the Post-CDK4/6 Treatment Line Oncology Drugs Market CAGR Value The global post-CDK4/6 treatment line oncology drugs market size was valued at USD 3.53 billion in 2025 and is expected to reach USD 10.06 billion by 2033, at a CAGR of 14.00% during the forecast period The...

0 التعليقات 0 المشاركات 61 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Vanshika04 أضاف وظيفة جديدة Health
2026-06-05 09:39:31 - ترجمة -

Lymphoma Treatment Market Growth Potential Driven by Advances in Cancer Therapeutics
The lymphoma treatment market is witnessing significant growth as healthcare providers increasingly focus on improving outcomes for patients diagnosed with Hodgkin lymphoma and non-Hodgkin lymphoma. Rising cancer prevalence, advancements in oncology research, and the growing adoption of innovative treatment approaches are contributing to the expansion of the market. The development of targeted...

0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!